Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
  News Analysis
  Corporate Action
  Other Market
  Company Profile
Derivatives
IPO
BSE Company News
Glaxosmithkline Pharmaceuticals Ltd.
BSE Code 500660
ISIN Demat INE159A01016
Book Value (Rs) 98.85
NSE Code GLAXO
Dividend Yield % 1.32
Market Cap(Rs Mn) 409149.45
TTM PE(x) 61.17
TTM EPS(Rs) 39.49
Face Value (Rs) 10  
Industry : Pharmaceuticals & Drugs
  
01-Oct-2024 Glaxosmithkline Pharmaceuticals informs about los...
24-Sep-2024 GlaxoSmithKline Pharmaceuticals informs about iss...
26-Aug-2024 GlaxoSmithKline Pharmaceuticals informs about di...
14-Aug-2024 GlaxoSmithKline Pharmaceuticals informs about iss...
13-Aug-2024 GlaxoSmithKline Pharmaceuticals informs about iss...
08-Aug-2024 Glaxosmithkline Pharmaceuticals informs about ana...
06-Aug-2024 GlaxoSmithKline Pharmaceuticals informs about out...
30-Jul-2024 GlaxoSmithKline Pharmaceuticals informs about iss...
22-Jul-2024 GlaxoSmithKline Pharmaceuticals informs about iss...
17-Jul-2024 Glaxosmithkline Pharmaceuticals board to consider...
04-Jul-2024 Glaxosmithkline Pharmaceuticals informs about com...
27-Jun-2024 GlaxoSmithKline Pharmaceuticals informs about clo...
27-Jun-2024 GlaxoSmithKline Pharmaceuticals informs about iss...
26-Jun-2024 GlaxoSmithKline Pharmaceuticals informs about iss...
24-Jun-2024 Glaxosmithkline Pharmaceuticals informs about los...
Page 1 of 3
Prev || Next